Cadron, I.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Application of proteomics in ovarian cancer: Which sample should be used?

Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, Frederic Amant, Etienne Waelkens, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 180 KB

english, 2009

2

Chemotherapy for cervical cancer

Isabelle Cadron, Frederic Amant, Ignace Vergote

Journal:

European Clinics in Obstetrics and Gynaecology

Year:

2005

Language:

english

File:

PDF, 126 KB

english, 2005

3

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

Van Gorp, T, Cadron, I, Despierre, E, Daemen, A, Leunen, K, Amant, F, Timmerman, D, De Moor, B, Vergote, I

Journal:

British Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 423 KB

english, 2011

4

Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients

IGNACE VERGOTE, BRAM POUSEELE, TOON VAN GORP, BERNARD VAN ACKER, KARIN LEUNEN, ISABELLE CADRON, PATRICK NEVEN, FREDERIC AMANT

Journal:

Acta Obstetricia et Gynecologica Scandinavica

Year:

2008

Language:

english

File:

PDF, 205 KB

english, 2008

5

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

Frederik Marmé, Thomas Hielscher, Sarah Hug, Sandra Bondong, Robert Zeillinger, Dan Cacsire Castillo-Tong, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Cadron Isabella, Sven Mahner, Irmgard Ferschke,

Journal:

International Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 939 KB

english, 2012

6

Genomic aberrations relate early and advanced stage ovarian cancer

Afra Zaal, Wouter J. Peyrot, P. M. J. J. Berns, Maria E. L. van der Burg, Jan H. W. Veerbeek, J. Baptist Trimbos, Isabelle Cadron, Paul J. van Diest, Wessel N. van Wieringen, Oscar Krijgsman, Gerrit A

Journal:

Cellular Oncology

Year:

2012

Language:

english

File:

PDF, 637 KB

english, 2012

7

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

Frederic Amant, Isabelle Cadron, Luca Fuso, Patrick Berteloot, Eric de Jonge, Gerd Jacomen, Johan Van Robaeys, Patrick Neven, Philippe Moerman, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 167 KB

english, 2005

8

M.M. Boyiadzis, P.F. Lebowitz, J.N. Frame, T. Fojo, ,Hematology-oncology therapy (2007) McGraw Hill Medical.

Isabelle Cadron, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 72 KB

english, 2007

9

The “Leuven” dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer

Isabelle Cadron, Karin Leunen, Frédéric Amant, Toon Van Gorp, Patrick Neven, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 310 KB

english, 2007

10

Chemotherapy for recurrent cervical cancer

Isabelle Cadron, Toon Van Gorp, Frederic Amant, Karin Leunen, Patrick Neven, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 157 KB

english, 2007

11

The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells

Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, Catherina Luyten, Katrien Drijkoningen, Frederic Amant, Karin Leunen, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2010

Language:

english

File:

PDF, 671 KB

english, 2010

12

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature

F.rédéric Amant, Philippe Moerman, Isabelle Cadron, Anne Hagemeijer, Ignace Vergote, Maria Debiec-Rychter

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 126 KB

english, 2003

13

The diagnostic problem of endometrial stromal sarcoma: report on six cases

Frédéric Amant, Philippe Moerman, Isabelle Cadron, Patrick Neven, Patrick Berteloot, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 814 KB

english, 2003

14

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Dietmar Pils, Gudrun Hager, Dan Tong, Stefanie Aust, Georg Heinze, Maria Kohl, Eva Schuster, Andrea Wolf, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Isabelle Cadron, Sven Mahner, Gerda Hofstetter, P

Journal:

Year:

2012

Language:

english

File:

PDF, 210 KB

english, 2012

15

Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patients

Dimitris Tsolakidis, Frederic Amant, Karin Leunen, Isabelle Cadron, Patrick Neven, Ignace Vergote

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 309 KB

english, 2011

16

Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses

Toon Van Gorp, Joan Veldman, Ben Van Calster, Isabelle Cadron, Karin Leunen, Frederic Amant, Dirk Timmerman, Ignace Vergote

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 308 KB

english, 2012

17

Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer

Sofie Torfs, Isabelle Cadron, Frederic Amant, Karin Leunen, Patrick Berteloot, Ignace Vergote

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 262 KB

english, 2012

18

Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer—a study by the OVCAD consortium

Andreas Melmer, Linda Fineder, Claudia Lamina, Barbara Kollerits, Benjamin Dieplinger, Ioana Braicu, Jalid Sehouli, Isabelle Cadron, Ignace Vergote, Sven Mahner, Alain G. Zeimet, Dan Cacsire Castillo-

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 401 KB

english, 2013

19

The “Leuven” paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study

Isabelle Cadron, Leyla Abdulkadir, Evelyn Despierre, Patrick Berteloot, Patrick Neven, Karin Leunen, Frédéric Amant, Ignace Vergote

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 197 KB

english, 2013

20

Improving outcome in the first-line management of advanced ovarian cancer

Ignace Vergote, Toon Van Gorp, Isabelle Cadron, Karin Leunen, Patrick Neven, Frederic Amant

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 311 KB

english, 2007

21

Obstetric and perinatal outcome of 1655 ICSI and 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births: a comparative analysis

Willem Ombelet, Isabelle Cadron, Jan Gerris, Petra De Sutter, Eugene Bosmans, Guy Martens, Gunther Ruyssinck, Paul Defoort, Geert Molenberghs, Wilfried Gyselaers

Journal:

Reproductive BioMedicine Online

Year:

2005

Language:

english

File:

PDF, 180 KB

english, 2005

22

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, Bart De Moor, Etienne Waelkens, Ignace Vergote

Journal:

Proteome Science

Year:

2012

Language:

english

File:

PDF, 237 KB

english, 2012

23

Management of Borderline Ovarian Neoplasms

Cadron, I., Leunen, K., Van Gorp, T., Amant, F., Neven, P., Vergote, I.

Journal:

Journal of Clinical Oncology

Year:

2007

Language:

english

File:

PDF, 132 KB

english, 2007

24

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Hofstetter, G., Concin, N., Braicu, I., Chekerov, R., Sehouli, J., Cadron, I., Van Gorp, T., Trillsch, F., Mahner, S., Ulmer, H., Grimm, C., Castillo-Tong, D. Cacsire, Zeillinger, R., Zeimet, A.G., Ve

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 376 KB

english, 2013

25

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N

Journal:

British Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 367 KB

english, 2011

26

[IEEE 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference - Shanghai, China (2006.01.17-2006.01.18)] 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference - Predictive Models for Long Term Survival after Premature Rupture of Membranes

Ameye, L., De Brabanter, J., Suykens, J.A.K., Cadron, I., Devlieger, R., Timmerman, D., Spitz, B., Van Huffel, S.

Year:

2005

Language:

english

File:

PDF, 144 KB

english, 2005

27

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF- B activation

Bondong, S., Kiefel, H., Hielscher, T., Zeimet, A. G., Zeillinger, R., Pils, D., Schuster, E., Castillo-Tong, D. C., Cadron, I., Vergote, I., Braicu, I., Sehouli, J., Mahner, S., Fogel, M., Altevogt,

Journal:

Annals of Oncology

Year:

2012

Language:

english

File:

PDF, 237 KB

english, 2012

28

Team- Sport and Individual Sport

Famaey-Lamon, A., Hebbelinck, M., Cadron, A.M.

Journal:

International Review for the Sociology of Sport

Year:

1979

Language:

english

File:

PDF, 603 KB

english, 1979

29

Intraperitoneal Chemotherapy in Patients with Advanced Ovarian Cancer: The Con View

Vergote, I., Amant, F., Leunen, K., Cadron, I., Van Gorp, T., Neven, P., Berteloot, P.

Journal:

Year:

2008

Language:

english

File:

PDF, 436 KB

english, 2008

30

Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV

Polterauer, Stephan, Vergote, Ignace, Concin, Nicole, Braicu, Ioana, Chekerov, Radoslav, Mahner, Sven, Woelber, Linn, Cadron, Isabelle, Gorp, Toon Van, Zeillinger, Robert, Castillo-Tong, Dan Cacsire,

Journal:

International Journal of Gynecological Cancer

Year:

2012

Language:

english

File:

PDF, 887 KB

english, 2012

31

The management of borderline tumours of the ovary

Cadron, Isabelle, Amant, Frederic, Van Gorp, Toon, Neven, Patrick, Leunen, Karin, Vergote, Ignace

Journal:

Current Opinion in Oncology

Year:

2006

Language:

english

File:

PDF, 104 KB

english, 2006

32

The utility of proteomics in gynecologic cancers

Van Gorp, Toon, Cadron, Isabelle, Vergote, Ignace

Journal:

Current Opinion in Obstetrics & Gynecology

Year:

2011

Language:

english

File:

PDF, 176 KB

english, 2011

33

Outcome and Clinical Management of 275 Patients With Advanced Ovarian Cancer International Federation of Obstetrics and Gynecology II to IV Inside the European Ovarian Cancer Translational Research Consortium—OVCAD

Chekerov, Radoslav, Braicu, Ioana, Castillo-Tong, Dan Cacsire, Richter, Rolf, Cadron, Isabelle, Mahner, Sven, Woelber, Linn, Marth, Christian, Van Gorp, Toon, Speiser, Paul, Zeillinger, Robert, Vergot

Journal:

International Journal of Gynecological Cancer

Year:

2013

Language:

english

File:

PDF, 1.01 MB

english, 2013

34

Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

Leunen, Karin, Cadron, Isabelle, Van Gorp, Toon, Amant, Frédéric, Berteloot, Patrick, Neven, Patrick, Legius, Eric, Vergote, Ignace

Journal:

International Journal of Gynecological Cancer

Year:

2009

Language:

english

File:

PDF, 530 KB

english, 2009